Success Stories: NIW Approved for Postdoctoral Scholar in Chemical Biology After RFE Response Prepared by NAILG
Client’s Testimonial:
“I’m incredibly grateful to NAILG for their expert guidance and unwavering support throughout my NIW petition process. Their strategic approach, deep understanding of my research in glycan synthesis and chemical biology, and meticulous preparation of the petition played a pivotal role in securing my approval. I highly recommend their services to any researcher pursuing immigration through the NIW path.”
On May 2nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Chemical Biology (Approval Notice).
General Field: Chemical Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: China
State of Residence at the Time of Filing: Georgia
Approval Notice Date: May 2nd, 2025
Processing Time: 1 year, 12 days
Case Summary:
A researcher at the forefront of chemical biology and glycan analysis partnered with The North America Immigration Law Group (NAILG) to pursue a National Interest Waiver (NIW) petition based on his original contributions, international recognition, and consistent scholarly impact. His work has significantly advanced the design, synthesis, and profiling of glycan molecules - complex carbohydrates that play key roles in many biological processes and disease mechanisms.
Our client’s research has led to key breakthroughs in glycomics and chemoenzymatic synthesis, including novel methods for synthesizing human milk oligosaccharides (HMOs), an efficient approach to producing O-mannosyl glycans relevant to neuromuscular disorders, and new technologies for quantitative O-glycomics that improve glycan structure profiling.
These contributions are considered foundational by peers in the field, helping to overcome longstanding barriers in the scalable production and study of glycans for both therapeutic and diagnostic purposes. His scholarly record reflects both productivity and global impact:
● 11 peer-reviewed journal articles, including 2 first-authored and 3 co-first-authored, 4 scientific abstracts
● His work has been cited 242 times by researchers in at least 24 countries
● He has completed at least 20 peer reviews, supporting the evaluation and advancement of chemical research
● His research has been supported by the National Institutes of Health (NIH), underscoring its relevance and competitiveness
As one leading recommender stated:"In summary, [client] has addressed critical limitations faced in profiling and studying O-glycans through his innovative application of microwave-assisted parallel synthesis techniques to produce a diverse library of O-glycan variants. His skillset, which has allowed him to do so, doubtlessly serves as a virtual guarantee of his ability to achieve further successes in his research, marking him as an invaluable asset within the field of chemical biology. [Client]’s creativity and innovative thinking, coupled with his expertise, will be a huge asset to chemical science in the United States. There is no doubt he will continue to have a major impact in the field of chemical biology. [Client] is one of top researchers with extraordinary ability in this country, and retaining him would be a great boon to science, medicine, and industry in the U.S. I am confident that he will continue to contribute substantially to the well-being of American society and help sustain the United States as the leading light in world science. Therefore, I strongly support his immigration petition to the United States."
NAILG collaborated with the client to develop a petition that clearly demonstrated the depth of his scientific contributions and their relevance to U.S. national interests. The case highlighted his innovations in glycan synthesis, consistent peer-reviewed output, international citation reach, and the broader biomedical value of his work. This comprehensive strategy led to a successful NIW approval, and we are proud to have played a key role in advancing his continued impact on U.S. science and public health.